Table 1.
Group A | Group B | pvalue | |
---|---|---|---|
N: 21 patients | N: 18 patients | ||
Sex | 0.442 | ||
Male* | 7 (33.3%) | 4 (22.2%) | |
Female* | 14 (66.7%) | 14 (77.8%) | |
Age (years)^ | 71.0 ± 5.0 | 70.9 ± 5.1 | 0.949 |
Weight (kg.)^ | 77.9 ± 5.3 | 77.1 ± 5.7 | 0.652 |
Height (cm.)^ | 174.0 ± 5.5 | 174.7 ± 5.5 | 0.687 |
BMI^ | 25.3±1.9 | 24.8±1.8 | 0.428 |
Primary tumor | 0.480 | ||
Lung* | 5 (23.9%) | 6 (33.3%) | |
Breast* | 9 (42.9%) | 9 (50%) | |
Unknown* | 7 (33.3%) | 3 (16.6%) | |
Symptoms | |||
Dyspnea* | 20 (95.3%) | 18 (100%) | 0.348 |
Cough* | 8 (38.1% ) | 7 (38.8%) | 0.959 |
Chest pain* | 10 (52.3%) | 9 (50%) | 0.882 |
Previous thoracocentesis | |||
Number/month^ | 4.7 ± 1.8 | 4.7 ± 1.5 | 0.926 |
Total amount (liters)^ | 2.7 ± 0.5 | 2.8 ± 0.4 | 0.246 |
Re-collection after (days)^ | 6.1 ± 2.3 | 6.7 ± 1.5 | 0.421 |
Relief of symptoms* | 21 (100%) | 18 (100%) | 1.00 |
Complete lung inflation* | 21 (100%) | 16 (87.8%) | 0.117 |
*Number (%).
^mean ± SD.